Welcome to industryreportstore.com

Need help? +44(0)20 7936 6830

Obesity market research, reports and industry analysis

mail

Contact us for professional industry advice

Email us or call

+44(0)20 7936 6830
mail

for FREE research alerts
to your inbox

8 Item(s)

Page 1 of 1

  1. Global Obesity Partnering 2010 to 2016

    By: Current Partnering
    , Published: Apr-2016
    , Product code: CP2222obe
    Provides understanding and access to the obesity partnering deals and agreements entered into by the worlds leading healthcare companies.
    $1,495.00

  2. Obsessive-Compulsive Disorder - Pipeline Review, H2 2015

    By: Global Markets Direct
    , Published: Jul-2015
    , Product code: GMDHC6878IDB
    Global Markets Direct’s, ‘Obsessive-Compulsive Disorder - Pipeline Review, H2 2015’, provides an overview of the Obsessive-Compulsive Disorder’s therapeutic pipeline.
    $2,000.00

  3. Anti-obesity Drugs Market in the US 2015-2019

    By: Technavio
    , Published: Jul-2015
    , Product code: IRTNTR6729
    TechNavio's report, Global CFRP Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the global CFRP market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
    $2,500.00

  4. Global Intragastric Balloons Market 2015-2019

    By: Technavio
    , Published: Jul-2015
    , Product code: IRTNTR6747
    TechNavio's report, Hair Care Market in GCC, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the GCC; it also covers the hair care market landscape in the GCC and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
    $2,500.00

  5. Obesity - Pipeline Review, H1 2015

    By: Global Markets Direct
    , Published: Feb-2015
    , Product code: GMDHC6235IDB
    Global Markets Direct’s, ‘Obesity - Pipeline Review, H1 2015’, provides an overview of the Obesity’s therapeutic pipeline.
    $2,000.00

  6. Global Anti-Obesity Drugs Market 2015-2019

    By: Technavio
    , Published: Nov-2014
    , Product code: IRTNTR4645
    TechNavio's report, the Global Anti-obesity Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the APAC and EMEA regions; it also covers the Global Anti-obesity Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
    $2,500.00

  7. Trends in Therapeutic Partnering

    By: Current Partnering
    , Published: Aug-2014
    , Product code: CP2290-
    Provides a detailed understanding and analysis of the 35 most popular therapeutic targets for partnering in the period 2009 to mid 2014
    $3,995.00

  8. Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity

    By: GBI Research
    , Published: Aug-2013
    , Product code: GBIHC302MR-
    GBI Research, the leading business intelligence provider, has released its latest research, “Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity”. Obesity is often described as a global endemic, with incidence dramatically increasing over the past decades, particularly in developed countries. Being overweight or obese is a major risk factor in the development of many chronic diseases, including cardiovascular diseases, cancer, and diabetes, of which treatment incurs extensive economic and healthcare costs. Numerous anti-obesity drugs have been approved in the past decade, including Knoll Pharmaceutical’s Meridia (sibutramine) and Acomplia (rimonabant), only for them to be removed from the market due to evidence of suicidal thoughts, depression and cardiovascular problems with their long-term use. As such, healthcare professionals have a negative perception of such drugs and do not widely prescribe them, a major barrier to the growth of the anti-obesity therapeutics market.
    $3,500.00

8 Item(s)

Page 1 of 1